Khepri Pharmaceuticals
Executive Summary
Completes $11 mil. venture financing, its third, and has raised $22.8 mil. to date. Leading the new round of financing was Schroder Ventures. Other new investors included SenMed Medical Ventures, Technology funding and Blue Cross/Blue Shield of Iowa. All current investors also participated. The South San Francisco- based protease/protease inhibitor R&D firm was founded by Genentech, which has an equity stake in the company